Status:
COMPLETED
A Study To Evaluate Whether Food Affects The Plasma Drug Levels Of A 35 mg Single Dose Of PF-04447943 Taken Orally In Healthy Adult Participants
Lead Sponsor:
Pfizer
Conditions:
Healthy
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of the study is to compare the plasma drug levels of PF-04447943 when taken as a 35 mg tablet after a high fat meal compared to when taken after fasting. Healthy adult volunteers will rece...
Eligibility Criteria
Inclusion
- Healthy male and/or female subjects, not of child bearing potential.
- Age 18-55 inclusive
- Total body weight \>50 kg.
Exclusion
- Evidence or history of clinical significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic diseases
- History of orthostatic blood pressure changes or orthostatic symptoms
- Greater than 7 drinks of alcohol per week for women and greater than 14 drinks per week for men
- Smoking more than 5 cigarettes per day
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00886093
Start Date
April 1 2009
End Date
May 1 2009
Last Update
July 2 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
New Haven, Connecticut, United States, 06511